Impedimed logo
IPD
Health Care Equipment & Services

Impedimed

Short interest
<0.01%
−0.33 pp 30d
as of 2 July 2026
Reported shorts
99.8K
Shares on issue
3.660B

Impedimed (IPD) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
20 July

ImpediMed Limited Announces Expiry of 2.6 Million Unquoted Options Due to Unmet Conditions

ImpediMed Limited (ASX: IPD) has informed the ASX that 2,635,000 unquoted options (IPDAAB) expired on 30 June 2026 following the lapse of conditional rights. These options, which had varying exercise prices and expiry dates, ceased due to failure to meet the attached conditions. Despite this lapse, the company’s issued capital structure remains largely unchanged, with ordinary shares and other option classes continuing to trade and remain outstanding. Key Highlights ImpediMed Limited (IPD) ...

Kalkine
Neutral
21 June

ImpediMed (ASX:IPD): Why Has This Healthcare Stock Suddenly Grabbed Attention?

Highlights A significant insider share purchase has placed ImpediMed back on the radar of market participants. The medical technology company continues to expand the commercial reach of its bioimpedance spectroscopy platform. Strong insider ownership activity has intensified focus on the company's long-term healthcare growth strategy. ImpediMed is drawing renewed attention following major insider buying activity, healthcare technology innovation and expanding opportunities in patient monitori...

Kalkine
Positive
21 May

Why IPD Group Shares Are Falling Despite A Massive 12-Month Rally

Highlights IPD Group shares fell sharply after releasing FY26 earnings guidance. The company still expects strong earnings growth across multiple divisions. Markets may be reacting to elevated expectations following a major share price rally. IPD shares fell despite positive guidance as markets reassessed expectations following a major share price rally. IPD Group Ltd (ASX:IPG) shares moved sharply lower on Thursday despite the company delivering guidance that still points toward strong earni...